Dhaval Patel, MD
Cardiovascular Disease · Marietta, GANPI 1831151174
Payments from drug & device makers
Across 508 payments — averaging $143.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$52K
- United Therapeutics Corporation$8K
- Actelion Pharmaceuticals US, Inc.$4K
- Novartis$1K
- Merck$1K
- Pfizer$992
- plus $5K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 96 | $52,458 |
| United Therapeutics Corporation | 48 | $8,430 |
| Actelion Pharmaceuticals US, Inc. | 37 | $3,535 |
| Novartis | 50 | $1,115 |
| Merck | 43 | $1,035 |
| Pfizer | 41 | $992 |
| Amgen | 24 | $774 |
| Bayer | 27 | $730 |
| Johnson & Johnson | 29 | $647 |
| Boehringer Ingelheim | 28 | $522 |
| E.r. Squibb & Sons, L.L.C. | 18 | $350 |
| Boston Scientific | 8 | $336 |
| Medtronic(2 entities) | 2 | $198 |
| AstraZeneca | 10 | $187 |
| ZOLL Respicardia, Inc. | 1 | $158 |
| Penumbra, Inc. | 1 | $149 |
| Esperion Therapeutics, Inc. | 7 | $129 |
| Novo Nordisk | 6 | $123 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $118 |
| Asahi Intecc USA, Inc. | 1 | $112 |
| Agepha Pharma FZ LLC | 1 | $100 |
| Dentsply Sirona Inc | 1 | $100 |
| Abbott | 1 | $92 |
| Edwards Lifesciences | 2 | $57 |
| Sanofi-aventis U.S. LLC | 2 | $53 |
| Cvrx, Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $45 |
| Abiomed | 1 | $33 |
| Gilead | 2 | $33 |
| Recor Medical Inc | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| GSK | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| Sandoz | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Bridgebio Pharma, Inc. | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Chiesi USA, Inc. | 1 | $15 |
How this compares
$72,921 in reported general payments places this provider in the 90th percentile of 640 cardiovascular disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Marietta
- Hans LeeMarietta$85K
- George KramerMarietta$63K
- Narendra SinghJohns Creek$5.4M
- Elizabeth OfiliAtlanta$4.5M
- Sanjay YadavAtlanta$3.7M
- Arshed QuyyumiAtlanta$3.4M
- Naresh ParikhNorcross$2.8M
- Nicolas ChronosEatonton$2.4M
- Bobby KhanAtlanta$1.7M
- Hunter ChampionColumbus$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.